We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Kadant's (KAI) Buyout of Clouth to Enhance Product Offerings
Read MoreHide Full Article
Kadant Inc. (KAI - Free Report) , on Jun 17, announced that it has entered into a deal to buy Joh. Clouth GmbH & Co. KG, along with its affiliates (“Clouth”). The buyout, which is expected to be completed in the third quarter of 2021 subject to certain regulatory approvals, is valued at about €78 million in cash.
Kadant’s shares declined 2.3% in the past couple of days to eventually close the trading session at $169.08 on Friday.
Inside the Headlines
Hückeswagen, Germany-based Clouth is engaged in manufacturing doctor blades and related equipment. The company’s products and services are sold across more than 70 countries in the world, supported by an extensive network of commercial representatives. Notably, in 2020, the company generated revenues of about €41 million.
The acquisition will enable Kadant to strengthen its position in the paper, packaging and tissue industry across Europe, North America and Asia. Notably, the addition of Clouth’s strong portfolio of products is likely to enable Kadant to provide a comprehensive line of doctor blades solution to its customers.
On completion of the deal, Clouth will be incorporated into Kadant’s Flow Control operating segment. Notably, the Flow Control segment is the provider of custom-engineered products, systems and technologies that are used for controlling the flow of fluids in commercial and industrial applications. In first-quarter 2021, the segment reported revenues of $63.8 million, reflecting growth of 11.7% on a year-over-year basis.
Zacks Rank, Price Performance and Estimate Revisions
Kadant, with approximately $2 billion market capitalization, currently carries a Zacks Rank #3 (Hold). The company is likely to benefit from solid portfolio of products and solutions, acquired assets and improving market conditions. However, high costs and expenses are concerns.
In the past six months, the company’s share price has increased 22.5% compared with the industry’s growth of 9.3%.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for its earnings is pegged at $6.07 for 2021, up 4.1% from the 60-day-ago figure. The consensus estimate for 2022 earnings is pegged at $6.67, up 1.8% over the same time frame.
Dover delivered an earnings surprise of 21.35%, on average, in the trailing four quarters.
EnPro delivered an earnings surprise of 319.18%, on average, in the trailing four quarters.
Helios delivered an earnings surprise of 50.69%, on average, in the trailing four quarters.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Image: Bigstock
Kadant's (KAI) Buyout of Clouth to Enhance Product Offerings
Kadant Inc. (KAI - Free Report) , on Jun 17, announced that it has entered into a deal to buy Joh. Clouth GmbH & Co. KG, along with its affiliates (“Clouth”). The buyout, which is expected to be completed in the third quarter of 2021 subject to certain regulatory approvals, is valued at about €78 million in cash.
Kadant’s shares declined 2.3% in the past couple of days to eventually close the trading session at $169.08 on Friday.
Inside the Headlines
Hückeswagen, Germany-based Clouth is engaged in manufacturing doctor blades and related equipment. The company’s products and services are sold across more than 70 countries in the world, supported by an extensive network of commercial representatives. Notably, in 2020, the company generated revenues of about €41 million.
The acquisition will enable Kadant to strengthen its position in the paper, packaging and tissue industry across Europe, North America and Asia. Notably, the addition of Clouth’s strong portfolio of products is likely to enable Kadant to provide a comprehensive line of doctor blades solution to its customers.
On completion of the deal, Clouth will be incorporated into Kadant’s Flow Control operating segment. Notably, the Flow Control segment is the provider of custom-engineered products, systems and technologies that are used for controlling the flow of fluids in commercial and industrial applications. In first-quarter 2021, the segment reported revenues of $63.8 million, reflecting growth of 11.7% on a year-over-year basis.
Zacks Rank, Price Performance and Estimate Revisions
Kadant, with approximately $2 billion market capitalization, currently carries a Zacks Rank #3 (Hold). The company is likely to benefit from solid portfolio of products and solutions, acquired assets and improving market conditions. However, high costs and expenses are concerns.
In the past six months, the company’s share price has increased 22.5% compared with the industry’s growth of 9.3%.
The Zacks Consensus Estimate for its earnings is pegged at $6.07 for 2021, up 4.1% from the 60-day-ago figure. The consensus estimate for 2022 earnings is pegged at $6.67, up 1.8% over the same time frame.
Stocks to Consider
Some better-ranked stocks from the same space are Dover Corporation (DOV - Free Report) , EnPro Industries, Inc. (NPO - Free Report) and Helios Technologies, Inc. (HLIO - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Dover delivered an earnings surprise of 21.35%, on average, in the trailing four quarters.
EnPro delivered an earnings surprise of 319.18%, on average, in the trailing four quarters.
Helios delivered an earnings surprise of 50.69%, on average, in the trailing four quarters.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How to Profit from Trillions on Spending for Infrastructure >>